{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:41:00Z","timestamp":1777628460981,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["RC-GCC2021-001"],"award-info":[{"award-number":["RC-GCC2021-001"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["ZL2024H016"],"award-info":[{"award-number":["ZL2024H016"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170164"],"award-info":[{"award-number":["82170164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370156"],"award-info":[{"award-number":["82370156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbrc.2026.153493","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:38:46Z","timestamp":1771400326000},"page":"153493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["FOSL2 drives acute myeloid leukemogenesis through suppression of ERAD-induced proteostatic collapse"],"prefix":"10.1016","volume":"809","author":[{"given":"Wangshi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingzhi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxing","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruolin","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8637-0054","authenticated-orcid":false,"given":"Keyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8250-3696","authenticated-orcid":false,"given":"Huitao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153493_bib1","article-title":"Introduction to the review series on advances in acute myeloid leukemia (AML)","volume":"127","author":"Lowenberg","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153493_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","article-title":"Acute myeloid leukaemia","volume":"392","author":"Short","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.153493_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n2026","article-title":"Advances in acute myeloid leukemia","author":"Newell","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.bbrc.2026.153493_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature22993","article-title":"Tracing the origins of relapse in acute myeloid leukaemia to stem cells","volume":"547","author":"Shlush","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153493_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","article-title":"AML treatment: conventional chemotherapy and emerging novel agents","volume":"45","author":"Forsberg","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2026.153493_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41375-020-01069-1","article-title":"New strategies to treat AML: novel insights into AML survival pathways and combination therapies","volume":"35","author":"Nair","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2026.153493_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153493_bib8","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in Acute Myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153493_bib9","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1200\/JCO.2009.25.1066","article-title":"Effect of complete remission and responses less than complete remission on survival in Acute Myeloid leukemia: a combined Eastern cooperative oncology group, Southwest oncology group, and M. D. Anderson cancer Center Study","volume":"28","author":"Walter","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.153493_bib10","first-page":"14","article-title":"Emerging agents and regimens for AML","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153493_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35806","article-title":"Therapeutic horizon of acute myeloid leukemia: success, optimism, and challenges","volume":"131","author":"Senapati","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2026.153493_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbcan.2019.04.003","article-title":"The AP-1 transcriptional complex: local switch or remote command?","volume":"1872","author":"Bejjani","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bbrc.2026.153493_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature07019","article-title":"Osteoclast size is controlled by Fra-2 through LIF\/LIF-receptor signalling and hypoxia","volume":"454","author":"Bozec","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153493_bib14","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.0801414105","article-title":"Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1","volume":"105","author":"Eferl","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2026.153493_bib15","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1084\/jem.20160514","article-title":"Fra-2 regulates B cell development by enhancing IRF4 and Foxo1 transcription","volume":"214","author":"Ubieta","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2026.153493_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107826","article-title":"The AP1 transcription factor Fosl2 promotes systemic autoimmunity and inflammation by repressing treg development","volume":"31","author":"Renoux","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2026.153493_bib17","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/en.2014-1566","article-title":"Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells","volume":"156","author":"DeMayo","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2026.153493_bib18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13046-021-02162-8","article-title":"SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop","volume":"40","author":"Bian","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153493_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biopha.2018.07.151","article-title":"MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-\u03b2\/Smad3 signaling pathway","volume":"107","author":"Sun","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153493_bib20","series-title":"Liver Cancer Development Driven by the AP-1\/c-Ju\u00f1Fra-2 Dimer Through c-Myc","first-page":"121","author":"Bakiri","year":"2024"},{"key":"10.1016\/j.bbrc.2026.153493_bib21","first-page":"168","article-title":"FOSL2-induced transcriptional activation of L1CAM promotes progression of lung adenocarcinoma via the PI3K\/AKT\/mTOR signaling pathway","author":"Feng","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2026.153493_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7150\/jca.81600","article-title":"TMBIM6-mediated miR-181a expression regulates breast cancer cell migration and invasion via the MAPK\/ERK signaling pathway","volume":"14","author":"Shin","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbrc.2026.153493_bib23","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.7150\/thno.55074","article-title":"FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts","volume":"11","author":"Wan","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2026.153493_bib24","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/sj.onc.1210984","article-title":"Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia","volume":"27","author":"Nakayama","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.153493_bib25","article-title":"ER as master regulator of membrane trafficking and organelle function","volume":"221","author":"Wenzel","year":"2022","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.bbrc.2026.153493_bib26","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.molcel.2021.05.004","article-title":"Maintenance of organellar protein homeostasis by ER-associated degradation and related mechanisms","volume":"81","author":"Lemberg","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2026.153493_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cell.2016.05.048","article-title":"Autoubiquitination of the Hrd1 ligase triggers protein retrotranslocation in ERAD","volume":"166","author":"Baldridge","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153493_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41556-020-0473-4","article-title":"Hrd1 forms the retrotranslocation pore regulated by auto-ubiquitination and binding of misfolded proteins","volume":"22","author":"Vasic","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153493_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz2449","article-title":"Structural basis of ER-associated protein degradation mediated by the Hrd1 ubiquitin ligase complex","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.153493_bib30","article-title":"Structural insights into the human HRD1 ubiquitin ligase complex","volume":"16","author":"Guo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153493_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41580-023-00633-8","article-title":"Mechanisms of substrate processing during ER-associated protein degradation","volume":"24","author":"Christianson","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153493_bib32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ncb1689","article-title":"OS-9 and GRP94 deliver mutant \u03b11-antitrypsin to the Hrd1\u2013SEL1L ubiquitin ligase complex for ERAD","volume":"10","author":"Christianson","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153493_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01321-x","article-title":"CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer","volume":"20","author":"Fan","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.153493_bib34","article-title":"Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression","volume":"19","author":"Fan","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrc.2026.153493_bib35","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/1878-0261.12856","article-title":"HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple\u2010negative breast cancer","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153493_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-018-3447-0","article-title":"Upregulation of HRD1 promotes cell migration and invasion in colon cancer","volume":"454","author":"Tan","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2026.153493_bib37","article-title":"E3 ubiquitin ligase HRD1 promotes lung tumorigenesis by promoting Sirtuin 2 ubiquitination and degradation","volume":"40","author":"Liu","year":"2023","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153493_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nucmedbio.2021.02.006","article-title":"HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging","volume":"96\u201397","author":"Li","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bbrc.2026.153493_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2403038121","article-title":"ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcs","volume":"121","author":"Xiang","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2026.153493_bib40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153493_bib41","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153493_bib42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrc1209","article-title":"AP-1: a double-edged sword in tumorigenesis","volume":"3","author":"Eferl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.153493_bib43","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153493_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153493_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01228-0","article-title":"Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies","volume":"15","author":"Padella","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153493_bib46","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI71264","article-title":"HSC commitment\u2013associated epigenetic signature is prognostic in acute myeloid leukemia","volume":"124","author":"Bartholdy","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.153493_bib47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood-2008-10-187203","article-title":"Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome","volume":"114","author":"Mills","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.153493_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150667","article-title":"HDAC1 promotes basal autophagy and proliferation of colorectal cancer cells by mediating ATG16L1 deacetylation","volume":"735","author":"Gao","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153493_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120620","article-title":"HRD1 in human malignant neoplasms: molecular mechanisms and novel therapeutic strategy for cancer","volume":"301","author":"Karamali","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2026.153493_bib50","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/leu.2011.172","article-title":"Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML","volume":"25","author":"de Jonge","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2026.153493_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2025.100017","article-title":"Targeting USP10\u2013FAK pathway sensitizes BCR-ABL+ leukemia cells to tyrosine kinase inhibitors","volume":"1","author":"Qiu","year":"2025","journal-title":"Cell Investigation"},{"key":"10.1016\/j.bbrc.2026.153493_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2025.100032","article-title":"S-palmitoylation: a novel player in cancer and its emerging therapeutic implications","volume":"1","author":"Wang","year":"2025","journal-title":"Cell Investigation"},{"key":"10.1016\/j.bbrc.2026.153493_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2025.100015","article-title":"ZDHHC9 mediates SMURF2 palmitoylation to promote lipid synthesis","volume":"1","author":"Dai","year":"2025","journal-title":"Cell Investigation"},{"key":"10.1016\/j.bbrc.2026.153493_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12935-020-01297-6","article-title":"GSK-J4 induces cell cycle arrest and apoptosis via ER stress and the synergism between GSK-J4 and decitabine in acute myeloid leukemia KG-1a cells","volume":"20","author":"Chu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2026.153493_bib55","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3390\/jcm3041466","article-title":"Targeted therapy of FLT3 in treatment of AML-Current status and future directions","volume":"3","author":"Engen","year":"2014","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.153493_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215603","article-title":"Resistance to mutant IDH inhibitors in acute myeloid leukemia: molecular mechanisms and therapeutic strategies","volume":"533","author":"Yao","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153493_bib57","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1111\/cas.14982","article-title":"VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell lines","volume":"112","author":"Kurozumi","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2026.153493_bib58","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41467-025-56520-7","article-title":"Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis","volume":"16","author":"Sun","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26002573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26002573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:44:45Z","timestamp":1777427085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26002573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"alternative-id":["S0006291X26002573"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153493","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOSL2 drives acute myeloid leukemogenesis through suppression of ERAD-induced proteostatic collapse","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153493"}}